Sanara MedTech Inc. SMTI Contingent Consideration Liability

Other financials

Revenue$27.8M+18.6%

Gross profit$25.9M+19.8%

Operating income$2.6M+221%

Net income$459.0K+113%

EPS (diluted)$0.05+112%

Cash & equivalents$13.6M-34.3%

Total debt$48.4M+8.2%

Total equity$7.0M-80.8%

Total assets$69.3M-28.1%

Operating cash flow-$2.5M-23.3%

CapEx$43.8K-97.5%

Free cash flow-$2.5M+32.6%

Market cap$216.18M-9.7%

Enterprise value$250.95M-6.5%

P/S2×-0.5×

Gross margin92.9%+1.8pp

Operating margin6.1%+5.1pp

Net margin-31.2%-93.4pp

FCF margin-9.8%-3.5pp

Return on equity-153.7%-199pp

Debt / equity6.9×+5.7×

Current ratio2.3×-0.5×

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept SMTI:ContingentConsiderationLiability.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Sanara MedTech Inc.'s contingent consideration liability?: Sanara MedTech Inc. (SMTI) reported contingent consideration liability of $0 in Q1 2026.